We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |


Am J Dis Child. 1930;39(6):1205-1213. doi:10.1001/archpedi.1930.01930180055005.
Text Size: A A A
Published online

Phenylethylhydantoin was introduced under the name "nirvanol"1 in 1916 as a sedative. The frequent occurrence of severe symptoms such as rash or fever led many authors2 to warn against its use. In 1919, Roeder3 recommended phenylethylhydantoin in the treatment for chorea minor.

The reports4 were so encouraging that we undertook a study of the action of this drug in a series of cases of chorea. Since chorea is a highly variable disease, no therapeutic study is convincing unless a fairly large number of cases is included, and unless comparison is made with cases in the same series in which the patients were treated by other methods. So far as we are aware, this has not been done previously. This report is based on the study of twenty-five cases; as the children entered the hospital, every other one was treated with phenylethylhydantoin. The dose for younger children


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.